Skip to main content
EQT Logo

LSP 4

Investments range between 5 million EUR and 15 million EUR.

LSP 4 seeks to invest in early-to-late-stage life sciences companies, developing novel and ground-breaking new medicines and technologies that provide solutions to unmet medical needs. LSP 4’s geographical focus is primarily Europe and occasionally the US.

Key Facts
Status

Active

Launch

2008

Size

88M EUR

SFDR classification

-

Head of fund

René R. Kuijten

LSP Advisory B.V.

Johannes Vermeerplein 9
1071 DV Amsterdam, the Netherlands

Company Registration Number: 34296447

LSP Advisory B.V. is an alternative investment fund manager authorized and regulated in accordance with laws of the Netherlands.

The Team

René R. Kuijten

René R. Kuijten

Partner, Head of EQT Life Sciences

About
Joachim Rothe

Joachim Rothe

Partner

About
John de Koning

John de Koning

Partner

About
Laurenz Govaerts

Laurenz Govaerts

Vice President

About
Martijn Kleijwegt

Martijn Kleijwegt

Partner

About
Philipp Bräuer

Philipp Bräuer

Vice President

About
Ishaan Tewarie

Ishaan Tewarie

Vice President

About
Maximilian Moser

Maximilian Moser

Vice President

About
Kevin Hammon

Kevin Hammon

Vice President

About
Christoph Broja

Christoph Broja

Partner

About
Daniela Begolo

Daniela Begolo

Managing Director

About
Prashanthi Ramesh

Prashanthi Ramesh

Associate

About
Abhiram Rao

Abhiram Rao

Director

About
Vincent Brichard

Vincent Brichard

Venture Partner

About

Do You Want to Learn More?

We are eager to explore how we can achieve great things together.

LSP 4 | EQT Portfolio